Related Experiment Video
Updated: Mar 3, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Perinatal selective serotonin reuptake inhibitor medication (SSRI) effects on social behaviors, neurodevelopment and
Mary Gemmel1, Eszter Bögi2, Christina Ragan3
1Department of Biological Sciences, Ohio University, Athens, OH, USA.
Insights
Perinatal exposure to selective serotonin reuptake inhibitors (SSRIs) may alter offspring social behaviors and neurodevelopment. This review examines SSRI impacts on maternal care, social behaviors, neurobiology, and the epigenome in developing children.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are increasingly used during pregnancy.
- Serotonin plays a crucial role in neurodevelopment and social behavior.
- Maternal SSRI use raises questions about potential effects on the developing child.
Purpose of the Study:
- To review the impact of perinatal SSRI exposure on maternal care and neurodevelopmental outcomes.
- To examine alterations in social behaviors, including play, social interactions, and reproduction.
- To discuss the effects on neurobiology and the epigenome.
Main Methods:
- Review of clinical research findings.
- Analysis of data from animal models.
- Synthesis of existing literature on SSRI effects.
Main Results:
- Perinatal SSRI exposure can modify maternal care and offspring social behaviors.
- Neurobiological and epigenetic changes are associated with early life SSRI exposure.
- Effects on social affiliative behaviors and reproductive outcomes are observed.
Conclusions:
- Understanding SSRI impacts is vital for child neurodevelopment and well-being.
- Further research is needed to fully elucidate the long-term consequences.
- This knowledge can inform clinical practice and improve intergenerational health outcomes.
Abstract:
Recent research has linked early life exposure to selective serotonin reuptake inhibitor medications (SSRIs) to modifications of social behaviors in children. Serotonin is a key regulator of neurodevelopment, social behaviors and mental health, and with the growing use of SSRIs to treat maternal affective disorders during the perinatal period, questions have been raised about the benefits and risks of perinatal SSRI exposure on the developing child. This review will highlight how perinatal SSRIs affect maternal care and neurodevelopmental outcomes related to social affiliative behaviors in offspring; such as play behaviors, social interactions, reproductive behaviors, and maternal care of the next generation. We will also review how early life exposure to SSRIs can alter related neurobiology, and the epigenome. Both clinical research and findings from animal models will be discussed. Understanding the impact of perinatal SSRIs on neurobehavioral outcomes will improve the health and well-being of subsequent generations.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
11:01Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
Related Concept Videos
Socioemotional Development during Infancy
Primary Temperament Types
Causes of Social Behavior III: Biological and Environmental Influences
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...